| pubmed-article:9182119 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9182119 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:9182119 | lifeskim:mentions | umls-concept:C0010416 | lld:lifeskim |
| pubmed-article:9182119 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9182119 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:9182119 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:9182119 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:9182119 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:9182119 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9182119 | pubmed:dateCreated | 1997-6-10 | lld:pubmed |
| pubmed-article:9182119 | pubmed:abstractText | The efficacy of combination therapy with 5-flucytosine and an IgG1 monoclonal antibody to Cryptococcus neoformans capsular glucuronoxylomannan was studied in vitro with J774. 16 murine macrophage-like cells and in vivo in murine cryptococcal infection. The combination of 5-flucytosine and IgG1 was more effective in reducing the numbers of C. neoformans colony-forming units in vitro and in vivo than either agent alone. | lld:pubmed |
| pubmed-article:9182119 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9182119 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9182119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9182119 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9182119 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9182119 | pubmed:issn | 0305-7453 | lld:pubmed |
| pubmed-article:9182119 | pubmed:author | pubmed-author:CasadevallAA | lld:pubmed |
| pubmed-article:9182119 | pubmed:author | pubmed-author:MukherjeeJJ | lld:pubmed |
| pubmed-article:9182119 | pubmed:author | pubmed-author:FeldmesserMM | lld:pubmed |
| pubmed-article:9182119 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9182119 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:9182119 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9182119 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9182119 | pubmed:pagination | 617-22 | lld:pubmed |
| pubmed-article:9182119 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:meshHeading | pubmed-meshheading:9182119-... | lld:pubmed |
| pubmed-article:9182119 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:9182119 | pubmed:articleTitle | Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro. | lld:pubmed |
| pubmed-article:9182119 | pubmed:affiliation | Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. | lld:pubmed |
| pubmed-article:9182119 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9182119 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9182119 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9182119 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9182119 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9182119 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9182119 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9182119 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9182119 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9182119 | lld:pubmed |
